Fundraising FoxMnemosyne Pharmaceuticals
Providence, US · Founded 2010 · Delaware corporation · 2 known investors
Find your way into Mnemosyne Pharmaceuticals
Sign up to see every warm intro you have to Mnemosyne Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Mnemosyne Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
VK
Vanessa KingExecutive
KP
Kollol PalExecutive
FM
Frank MennitiNamed on SEC filing
Board
RH
Richard HoranBoard director
PB
DB
Daniel BehrBoard director
JB
James BristolBoard director
WK
William KosterBoard director
BB
Benjamin BronsteinBoard director
Investors · 2
Atlas VenturereportedCambridge · $500K – $1M
How we know: funding news · Not right? Tell us
Clal Biotechnology IndustriesreportedTel Aviv
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$15.6M disclosed across 2 rounds · 2012
▶$12.3MraisedFeb 2015 · 6 investors · BiotechnologyRule 506(b)
▶$12.3MraisedFeb 2015 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James BristolDirector
- Frank MennitiExecutive Officer
- Richard HoranDirector
- Peter BarrettDirector
- Vanessa KingExecutive Officer, Director
- William KosterDirector
- Offering amount
- $13M
- Amount sold
- $12.3M
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
▶$3.2MraisedFeb 2012 · 4 investors · BiotechnologyRule 506(b)
▶$3.2MraisedFeb 2012 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard HoranDirector
- Daniel BehrDirector
- James BristolDirector
- Frank MennitiExecutive Officer
- Benjamin BronsteinDirector
- Kollol PalExecutive Officer, Director
- Offering amount
- $5.4M
- Amount sold
- $3.2M
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Mnemosyne Pharmaceuticals's investors?
- Mnemosyne Pharmaceuticals's investors include Atlas Venture, Clal Biotechnology Industries.
- How much funding has Mnemosyne Pharmaceuticals raised?
- Mnemosyne Pharmaceuticals has disclosed $15.6M raised across 2 rounds.
- Where is Mnemosyne Pharmaceuticals headquartered?
- Mnemosyne Pharmaceuticals is headquartered in Providence, US.